Methamphetamine use and cardiovascular disease: in search of answers

CG Kevil, NE Goeders, MD Woolard… - … , and vascular biology, 2019 - Am Heart Assoc
While the opioid epidemic has garnered significant attention, the use of methamphetamines
is growing worldwide independent of wealth or region. Following overdose and accidents …

A mechanistic and pathophysiological approach for stroke associated with drugs of abuse

A Tsatsakis, AO Docea, D Calina, K Tsarouhas… - Journal of Clinical …, 2019 - mdpi.com
Drugs of abuse are associated with stroke, especially in young individuals. The major
classes of drugs linked to stroke are cocaine, amphetamines, heroin, morphine, cannabis …

Stroke and methamphetamine use in young adults: a review

JM Lappin, S Darke, M Farrell - Journal of Neurology, Neurosurgery & …, 2017 - jnnp.bmj.com
Background Methamphetamine use and stroke are significant public health problems.
Strokes among people aged below 45 years are much less common than in older age …

The cardiac complications of methamphetamines

ED Paratz, NJ Cunningham, AI MacIsaac - Heart, Lung and Circulation, 2016 - Elsevier
Methamphetamines are increasingly popular drugs of abuse in Australia, and are rising in
purity. The rising popularity and purity of methamphetamines has notably increased …

Clinical characteristics, histopathological features, and clinical outcome of methamphetamine-associated cardiomyopathy

S Schuerer, K Klingel, M Sandri, N Majunke, C Besler… - JACC: Heart Failure, 2017 - jacc.org
Objectives: This study aimed to assess characteristics including endomyocardial biopsy and
outcome of patients with methamphetamine (MA)-associated cardiomyopathy in a series of …

Clinical characteristics and management of methamphetamine‐associated cardiomyopathy: state‐of‐the‐art review

PKV Reddy, TMH Ng, EE Oh, G Moady… - Journal of the …, 2020 - Am Heart Assoc
Methamphetamine‐associated cardiomyopathy (MACM) is an increasingly recognized
disease entity in the context of a rapidly spreading methamphetamine epidemic. MACM may …

The clinical toxicology of metamfetamine

LJ Schep, RJ Slaughter, DMG Beasley - Clinical Toxicology, 2010 - Taylor & Francis
Introduction. Metamfetamine is a highly addictive amfetamine analog that acts primarily as a
central nervous system (CNS) stimulant. The escalating abuse of this drug in recent years …

Rates, characteristics and circumstances of methamphetamine‐related death in Australia: a national 7‐year study

S Darke, S Kaye, J Duflou - Addiction, 2017 - Wiley Online Library
Aims To (1) assess trends in the number and mortality rates of methamphetamine‐related
death in Australia, 2009–15;(2) assess the characteristics and the cause, manner and …

Prevalence and nature of cardiovascular disease in methamphetamine-related death: a national study

S Darke, J Duflou, S Kaye - Drug and alcohol dependence, 2017 - Elsevier
Background Methamphetamine dependence is a major public health problem. This study
examined the nature, and extent, of cardiovascular disease amongst cases of …

The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?

S Kaye, S Darke - Addiction, 2012 - Wiley Online Library
Aims To examine the literature pertaining to the diversion and misuse of pharmaceutical
stimulants. Methods Relevant literature was identified through comprehensive MEDLINE …